The University of Chicago Header Logo

Erik Nelson

Concepts (176)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Presbycusis
8
2017
11
1.730
Why?
Temporal Bone
10
2014
68
1.520
Why?
Spiral Ganglion
9
2017
25
1.190
Why?
Cochlea
7
2017
50
0.880
Why?
Aging
3
2017
721
0.720
Why?
Otosclerosis
2
2014
6
0.700
Why?
Receptors, Estrogen
2
2016
394
0.570
Why?
Vestibular Nerve
1
2017
33
0.560
Why?
Goldfish
1
2016
6
0.550
Why?
Vitellogenins
1
2016
10
0.550
Why?
Taxoids
1
2016
124
0.540
Why?
Protein Precursors
1
2016
140
0.540
Why?
Hydroxycholesterols
1
2016
6
0.530
Why?
Selective Estrogen Receptor Modulators
1
2016
34
0.520
Why?
Cadherins
1
2016
163
0.520
Why?
Biological Assay
1
2016
79
0.520
Why?
Stria Vascularis
2
2006
5
0.500
Why?
Estrogen Receptor alpha
1
2016
148
0.500
Why?
Collagen Type I
2
2014
72
0.480
Why?
Keratan Sulfate
1
2014
4
0.470
Why?
Chondroitin Sulfates
1
2014
43
0.460
Why?
Triple Negative Breast Neoplasms
1
2016
163
0.460
Why?
Thyroid Hormones
1
2016
330
0.460
Why?
Cholesterol
1
2016
360
0.460
Why?
Cell Membrane
1
2016
675
0.440
Why?
Cell Movement
1
2016
785
0.430
Why?
Cochlear Nucleus
1
2011
6
0.400
Why?
Breast Neoplasms
2
2016
3020
0.390
Why?
DNA, Mitochondrial
5
2011
189
0.390
Why?
Liver
1
2016
1208
0.380
Why?
Cellular Senescence
1
2011
100
0.370
Why?
Hearing Loss, Sensorineural
3
2004
50
0.350
Why?
Obesity
2
2016
971
0.340
Why?
Biomarkers, Tumor
1
2016
1540
0.310
Why?
Hair Cells, Vestibular
1
2005
18
0.260
Why?
Antineoplastic Agents
1
2016
2327
0.250
Why?
Audiometry
4
2011
14
0.250
Why?
RNA Interference
2
2016
376
0.240
Why?
Female
15
2017
46371
0.230
Why?
Cell Death
3
2016
261
0.230
Why?
Microdissection
4
2011
18
0.220
Why?
Hair Cells, Auditory
3
2017
24
0.210
Why?
Immunohistochemistry
3
2014
1798
0.200
Why?
Cochlear Nerve
1
2001
9
0.200
Why?
Fluorescent Antibody Technique
3
2011
323
0.180
Why?
Humans
25
2017
89567
0.180
Why?
Organ of Corti
3
2006
10
0.180
Why?
Male
13
2017
42464
0.170
Why?
Aged
11
2017
19144
0.160
Why?
Collodion
2
2008
7
0.160
Why?
Sequence Deletion
2
2010
205
0.160
Why?
Retrospective Studies
6
2014
9112
0.160
Why?
Gene Deletion
2
2011
341
0.150
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2016
885
0.150
Why?
Aged, 80 and over
5
2014
6766
0.150
Why?
Cell Count
1
2017
199
0.140
Why?
Hearing
1
2017
57
0.140
Why?
Mice, Inbred NOD
1
2016
198
0.130
Why?
Lead
1
2016
26
0.130
Why?
Mice, SCID
1
2016
259
0.130
Why?
Lasers
3
2011
107
0.130
Why?
Estrogen Antagonists
1
2016
48
0.130
Why?
Crime
1
2016
37
0.130
Why?
Receptors, Thyroid Hormone
1
2016
160
0.130
Why?
MCF-7 Cells
1
2016
114
0.130
Why?
Environmental Pollutants
1
2016
52
0.130
Why?
Microscopy, Confocal
2
2014
278
0.130
Why?
Tumor Burden
1
2016
305
0.130
Why?
Workflow
1
2016
79
0.130
Why?
Age of Onset
1
2016
314
0.120
Why?
Middle Aged
9
2014
25996
0.120
Why?
Chemotherapy, Adjuvant
1
2016
477
0.120
Why?
Xenograft Model Antitumor Assays
1
2016
484
0.120
Why?
Neoplasm Invasiveness
1
2016
571
0.120
Why?
Triiodothyronine
1
2016
345
0.120
Why?
Atrophy
2
2006
122
0.120
Why?
Ligands
1
2016
446
0.120
Why?
Age Factors
2
2011
1877
0.120
Why?
Transfection
1
2016
909
0.110
Why?
Up-Regulation
1
2016
725
0.110
Why?
Neoadjuvant Therapy
1
2016
374
0.110
Why?
Reference Values
2
2011
661
0.110
Why?
Dose-Response Relationship, Drug
2
2016
1928
0.110
Why?
Cell Line, Tumor
2
2016
2582
0.110
Why?
Adult
9
2011
26684
0.100
Why?
Tissue Embedding
2
2011
6
0.100
Why?
Polymerase Chain Reaction
2
2011
919
0.100
Why?
Autopsy
1
2011
122
0.100
Why?
Skull Neoplasms
1
1991
30
0.090
Why?
Proteoglycans
1
2011
123
0.090
Why?
Cytochrome-c Oxidase Deficiency
1
2010
3
0.090
Why?
Cell Separation
1
2011
199
0.090
Why?
Child
5
2016
7214
0.090
Why?
RNA, Messenger
1
2016
2021
0.090
Why?
Gene Expression Regulation, Neoplastic
1
2016
1281
0.090
Why?
Receptor Protein-Tyrosine Kinases
1
2011
160
0.090
Why?
Case-Control Studies
2
2011
1862
0.090
Why?
Time Factors
2
2016
5333
0.080
Why?
Stapes Surgery
1
1989
6
0.080
Why?
Cadaver
2
2011
186
0.080
Why?
Proteomics
1
2010
231
0.080
Why?
Esophageal Neoplasms
1
2011
333
0.080
Why?
Chromosome Deletion
1
2009
226
0.080
Why?
Tissue Adhesives
1
2008
23
0.080
Why?
Stomach Neoplasms
1
2011
287
0.080
Why?
In Situ Nick-End Labeling
1
2008
122
0.080
Why?
Hearing Loss
1
2008
62
0.070
Why?
Severity of Illness Index
2
2011
1850
0.070
Why?
Animals
2
2016
27476
0.070
Why?
Bone and Bones
1
2008
271
0.070
Why?
Child, Preschool
3
2016
3754
0.060
Why?
Sensitivity and Specificity
2
2011
2015
0.060
Why?
Risk Factors
1
2016
5523
0.060
Why?
Adolescent
4
2011
9299
0.060
Why?
Linear Models
1
2006
421
0.060
Why?
Biopsy, Needle
1
2005
231
0.060
Why?
Adenocarcinoma
1
2011
1185
0.060
Why?
Citalopram
1
2003
20
0.060
Why?
Neurons
1
2011
1588
0.050
Why?
Bulimia
1
2003
141
0.050
Why?
Tobramycin
1
2001
9
0.050
Why?
Gentamicins
1
2001
20
0.050
Why?
Deafness
1
2001
48
0.050
Why?
Cochlear Implantation
1
2001
34
0.050
Why?
Apoptosis
1
2008
1717
0.050
Why?
Young Adult
1
2011
6362
0.040
Why?
Electron Transport Complex IV
2
2008
49
0.040
Why?
Feasibility Studies
2
2011
781
0.040
Why?
Missouri
1
2016
18
0.030
Why?
Cities
1
2016
42
0.030
Why?
Environmental Exposure
1
2016
330
0.030
Why?
Chondroitin Sulfate Proteoglycans
1
2011
36
0.020
Why?
Receptors, Growth Factor
1
2011
52
0.020
Why?
Indicators and Reagents
1
2011
72
0.020
Why?
Petrous Bone
1
1991
11
0.020
Why?
STAT3 Transcription Factor
1
2011
86
0.020
Why?
Hepatocyte Growth Factor
1
2011
84
0.020
Why?
Ear, Middle
1
1991
26
0.020
Why?
Fixatives
1
2010
12
0.020
Why?
Staining and Labeling
1
2011
168
0.020
Why?
Drug Administration Schedule
2
2003
865
0.020
Why?
Tissue Fixation
1
2010
40
0.020
Why?
Gene Dosage
1
2011
210
0.020
Why?
Formaldehyde
1
2010
52
0.020
Why?
In Situ Hybridization, Fluorescence
1
2011
352
0.020
Why?
Reference Standards
1
2011
144
0.020
Why?
Microscopy
1
2010
87
0.020
Why?
Infant, Newborn
1
2016
2487
0.020
Why?
Proto-Oncogene Proteins c-met
1
2011
199
0.020
Why?
Auditory Threshold
1
2009
15
0.020
Why?
Indoles
1
2011
300
0.020
Why?
Piperazines
1
2011
282
0.020
Why?
Receptor, ErbB-2
1
2011
247
0.020
Why?
RNA, Small Interfering
1
2011
557
0.020
Why?
Infant
1
2016
3174
0.020
Why?
Data Interpretation, Statistical
1
2011
300
0.020
Why?
Sulfonamides
1
2011
318
0.020
Why?
Proto-Oncogene Proteins
1
2011
665
0.020
Why?
DNA Primers
1
2008
543
0.020
Why?
Protein Kinase Inhibitors
1
2011
585
0.020
Why?
Base Sequence
1
2008
2329
0.010
Why?
Titrimetry
1
2003
15
0.010
Why?
Prognosis
1
2011
3783
0.010
Why?
Molecular Sequence Data
1
2008
3024
0.010
Why?
Depressive Disorder
1
2003
223
0.010
Why?
Audiometry, Pure-Tone
1
2001
25
0.010
Why?
Reproducibility of Results
1
2008
2763
0.010
Why?
Models, Biological
1
2008
1762
0.010
Why?
Drug Interactions
1
2001
244
0.010
Why?
Signal Transduction
1
2011
3395
0.010
Why?
Body Mass Index
1
2003
774
0.010
Why?
Mutation
1
2011
4159
0.010
Why?
Drug Therapy, Combination
1
2001
782
0.010
Why?
Double-Blind Method
1
2003
1708
0.010
Why?
Surveys and Questionnaires
1
2003
2641
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
2502
0.010
Why?
Nelson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (176)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_